Regulations.gov document
Letter from U S Patent and TradeMark Office to FDA CDER
Other · FDA-2020-E-2039 · posted Jan 13, 2021
Key facts
| Document ID | FDA-2020-E-2039-0004 |
|---|---|
| Title | Letter from U S Patent and TradeMark Office to FDA CDER |
| Document type | Other |
| Subtype | Letter(s) |
| Agency | FDA |
| Docket | FDA-2020-E-2039 |
| Posted | Jan 13, 2021 |
| Comment period opens | Jan 13, 2021 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: